Employees: 11-50
Portfolio 34
| Date | Name | Website | Total Raised | Location |
| 04.08.2023 | Vera Thera... | veratx.com | $80M | United Sta... |
| 23.06.2023 | United The... | unither.com | - | United Sta... |
| 26.05.2023 | Apellis | apellis.com | $140.1M | United Sta... |
| 26.10.2022 | Intra-Cell... | intracellulartherapies.com | - | United Sta... |
| 26.10.2022 | uniQure | uniqure.com | - | Netherland... |
| 26.10.2022 | Alkermes | alkermes.com | - | Ireland |
| 22.09.2022 | Exelixis | exelixis.com | - | United Sta... |
| 22.09.2022 | Supernus P... | supernus.com | $42M | United Sta... |
| 04.07.2022 | Harmony Bi... | harmonybiosciences.com | $270M | United Sta... |
| 04.07.2022 | Travere Th... | travere.com | $275M | United Sta... |
Show more
Mentions in press and media 7
| Date | Title | Description |
| 15.02.2022 | International Biotechnology Trust : Biotech – not a cyclical sector, but a cyclical investment environment | The biotech sector is driven by the consistent fundamentals of demand from an ageing population and supply from accelerating scientific innovation. These forces are unaffected by highs and low of economic cycles, giving the revenue generati... |
| 18.01.2022 | International Biotechnology Trust : 2021 - a year of two halves, optimistic for a recovery in 2022 | At the start of a third year in which the Covid pandemic will undoubtedly play a major role, we revisit 2021 which was disappointing for the biotech sector with a marked underperformance against the broader market, and look forward optimist... |
| 20.12.2021 | International Biotechnology Trust : Conditional drug approvals set to expand biotech universe | Crises are well-known for accelerating change, and the Covid-19 pandemic was no exception. Had the delivery of vaccines and therapies not been urgently fast-tracked, countless more lives could have been lost. Conditional drug approvals were... |
| 20.07.2021 | International Biotechnology Trust : Gene editing breakthrough to power next biotech boom | By Marek Poszepczynski and Ailsa Craig, co-investment managers of the International Biotechnology Trust Gene editing has made headlines in recent weeks, as the revolutionary technology has made breakthrough progress in treating serious gene... |
| 21.05.2021 | INTERNATIONAL BIOTECHNOLOGY TRUST PLC International Biotechnology Trust : Innovation is the key not the culprit – IP waiving is counterproductive | You may have heard of the Biden Administration's recent proposal to waive the patents for Covid-19 vaccines in order to speed up production and global distribution. In this blog we wanted to discuss why we think this is a mistake and why pa... |
| 21.04.2021 | INTERNATIONAL BIOTECHNOLOGY TRUST PLC International Biotechnology Trust : Navigating the three-phase trial process of biotech companies | As biotechnology experts, we are cautious about how certain companies in the sector are communicating. Recent high-profile examples have shown clinical data and the interpretation of regulatory interactions are often presented through a som... |
| 08.01.2021 | International Biotechnology Trust : Vaccine arrives - at warp speed | November was a good month for the sector and for the Trust. The NAV of the Trust increased by 4.8% (GBP), and the benchmark index (NBI) appreciated 7.8% (GBP). This strong performance of the NBI was partly driven by the extraordinary perfor... |